Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 412-570-1 | CAS number: 119462-56-5 PERKALINK 900
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- June-July 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well conducted study according to GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Principles of method if other than guideline:
- The effect of 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene on chromosome structure in bone marrow cells was investigated following acute oral administration to mice. Chromosome damage was measured indirectly by counting micronuclei.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
- EC Number:
- 412-570-1
- EC Name:
- 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
- Cas Number:
- 119462-56-5
- Molecular formula:
- Hill formula: C18 H16 N2 O4
- IUPAC Name:
- 3-methyl-1-({3-[(3-methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl]phenyl}methyl)-2,5-dihydro-1H-pyrrole-2,5-dione
- Details on test material:
- Batch no: BOM pp2
Purity: 87 ± 3% (m/M); see CoA attacahed
Other: m-Xylylene bis (itaconimide): 2-5%
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Duration of treatment / exposure:
- single application
- Frequency of treatment:
- single application
- Post exposure period:
- 24h after treatment for all treatment groups and additionally 48 and 72 h after treatment for 2500 and 3000 mg/kg bw groups
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 other: mg/kg
- Remarks:
- vehicle control; Sacrifice time: 24, 48, 72 hours
- Dose / conc.:
- 750 other: mg/kg
- Remarks:
- Sacrifice time: 24 hours
- Dose / conc.:
- 1 500 other: mg/kg
- Remarks:
- Sacrifice time: 24 hours
- Dose / conc.:
- 2 500 other: mg/kg
- Remarks:
- Sacrifice time: 24, 48, 72 hours
- Dose / conc.:
- 3 000 other: mg/kg
- Remarks:
- Sacrifice time: 24, 48, 72 hours
- No. of animals per sex per dose:
- Range finding: 750, 1500, 3000 and 5000 mg/kg bw
Main study: 5 mice/sex/group
0 mg/kg (vehicle control); Sacrifice time: 24, 48, 72 hours
750 mg/kg; Sacrifice time: 24 hours
1500 mg/kg; Sacrifice time: 24 hours
2500 mg/kg; Sacrifice time: 24, 48, 72 hours
3000 mg/kg; Sacrifice time: 24, 48, 72 hours - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- 30 mg/kg chlorambucil
Examinations
- Tissues and cell types examined:
- Bone marrow smears were prepared and stained for examination; 2000 erythrocytes per animals were analysed for the presence of micronuclei; the ratio of polychromatic versus normochromatic cells was calculated.
- Evaluation criteria:
- The test material will be designated an in vivo clastogen if a statistically and biologically significant increase in micronucleated polychromatic cells, compared to vehicle contro values, is seen in at least one treatment group, particularly if supported by evidence of a dose-related response.
- Statistics:
- Mann-Whitney U procedure, two-tailed test
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- see below
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
One male animal treated with BCI-MX at 3000 mg/kg was killed in extremis approximately 2 hours after dosing as a result of hunched posture, piloerection, inactivity and slow respiration. Another male animal dosed with BCI-MX at 2500 mg/kg was found dead approximately 4 hours after dosing, having previously showed signs of hunched posture and inactivity. All other animals survived to scheduled termination, although some animals dosed at 1500, 2500 and 3000 mg/kg showed intermittent signs throughout the study, inclUding hunched posture, piloerection, ungroomed fur at the base of the tail, reduced activity, and redness and swelling in the anal region.
There was some evidence of bone marrow toxicity, as evidenced by depression of bone marrow proliferation, on slides prepared from animals dosed with BCI-MX at 3000 mg/kg and sacrificed 48 or 72 hours later. Frequencies of micronucleated polychromatic erythrocytes in animals killed 24, 48 or 72 hours after administration of BCI-MX were similar to those in concurrent controls. This lack of treatment-related effect was apparent in both sexes, and was confirmed by statistical analysis. Statistically significant increases over controls were, however, seen in positive control group animals given chlorambucil at 30 mg/kg (p<0.01). It is concluded that, under the conditions of test, there was no evidence of induced chromosomal or other damage leading to micronucleus formation in polychromatic erythrocytes of treated mice 24, 48 or 72 hours after oral administration of BCI-MX. The test procedure was highly sensitive to the chromosome-damaging action of chlorambucil.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
- Executive summary:
In an in vivo mouse bone marrow micronucleus test performed according to OECD 474 (1983) male and female mice were given a single oral dose of the test substance in corn oil at 750, 1500, 2500 or 3000 mg/kg bw. Five males and five females from each group were killed 24 hours after treatment; further lots of five males and- five females given corn oil or 2500 or 3000mg/kg bw were killed 48 and 72 hours after treatment.
Besides on male in the 3000 and 2500 mg group each, all other animals survived to scheduled termination, although some animals dosed at 1500, 2500 and 3000 mg/kg showed intermittent clinical signs throughout the study, including hunched posture, piloerection, reduced activity, and redness and swelling in the anal region.
There was some evidence of bone marrow toxicity, as seen by depression of bone marrow proliferation on slides prepared from animals dosed with 3000 mg/kg and sacrificed 48 or 72 hours later. Frequencies of micronucleated polychromatic erythrocytes in animals killed 24, 48 or 72 hours after administration of the test substance were similar to those in concurrent controls. It is concluded that, under the conditions of test, there was no evidence of induced chromosomal leading to micronucleus formation in polychromatic erythrocytes of treated mice 24, 48 or 72 hours after oral administration of the test substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.